 <h1>Dysport Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>abobotulinumtoxinA</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about abobotulinumtoxinA. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Dysport.</p><h2>In Summary</h2><p><b>Common side effects of Dysport include:</b> dysphagia, headache, myasthenia, nasopharyngitis, voice disorder, and xerostomia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to abobotulinumtoxinA: intramuscular powder for solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Intramuscular route (Powder for Solution)</p><p>The effects of abobotulinumtoxinA and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults, particularly in those patients who have underlying conditions that would predispose them to these symptoms.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, abobotulinumtoxinA (the active ingredient contained in Dysport) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking abobotulinumtoxinA:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>decreased vision</li>
<li>difficulty with swallowing or speaking</li>
<li>double vision</li>
<li>dry eyes</li>
<li>eye pain</li>
<li>hoarseness</li>
<li>itching of the eyes</li>
<li>muscle or bone pain</li>
<li>muscle weakness</li>
<li>problems with focusing of the eyes</li>
<li>seeing double</li>
<li>seizures</li>
<li>stuffy or runny nose</li>
<li>sore throat</li>
<li>voice changes</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blistering, burning, crusting, dryness, or flaking of the skin</li>
<li>body aches or pain</li>
<li>chills</li>
<li>cough</li>
<li>cough producing mucus</li>
<li>diarrhea</li>
<li>difficult or labored breathing</li>
<li>ear congestion</li>
<li>fever</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>itching, scaling, severe redness, soreness, or swelling of the skin</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>loss of voice</li>
<li>muscle aches and pains</li>
<li>nausea</li>
<li>shivering</li>
<li>sneezing</li>
<li>stiff muscles</li>
<li>sweating</li>
<li>tightness in the chest</li>
<li>trouble sleeping</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>change in color vision</li>
<li>difficulty seeing at night</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>flushing or redness of the skin</li>
<li>hives, itching, rash</li>
<li>increased sensitivity of the eyes to sunlight</li>
<li>partial or slight paralysis of the face</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>unusually warm skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of abobotulinumtoxinA may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
<li>dry mouth</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Drooping upper eyelids</li>
<li>pain or tenderness around the eyes and cheekbones</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Dizziness or lightheadedness</li>
<li>feeling of constant movement of self or surroundings</li>
<li>sensation of spinning</li>
</ul><p>
<!-- end intramuscular powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to abobotulinumtoxinA: injectable powder for injection, intramuscular powder for injection</i></p><h3>General</h3><p>The most commonly occurring side effects have included muscular weakness, dysphagia, dry mouth, injection site pain and discomfort, fatigue, headache, and nasopharyngitis.</p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dysphonia (up to 28%), headache (11%), facial paresis (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, convulsion, syncope, hypoesthesia, partial seizures<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, peripheral edema<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dysphagia (up to 39%), dry mouth (up to 39%)</p>
<p><b>Common</b> (1% to 10%): Nausea, diarrhea, constipation, vomiting, gastroenteritis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, blood present in urine<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Abnormal liver function tests<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Anaphylaxis, urticaria, soft tissue edema</p>
<p><b>Postmarketing reports</b>: Hypersensitivity reactions including anaphylaxis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Blood triglycerides increased<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Eye disorders (e.g., vision blurred, diplopia, visual acuity reduced, eye pain, eyelid disorder, accommodation disorder, dry eye, eye pruritus) (up to 17%)</p>
<p><b>Common</b> (1% to 10%): Eyelid edema, eyelid ptosis</p>
<p><b>Postmarketing reports</b>: Photophobia<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site discomfort (e.g., pain, bruising, hemorrhage, injection site erythema/hematoma) (up to 22%)</p>
<p><b>Common</b> (1% to 10%): Injection site pain<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Nasopharyngitis (10%), upper respiratory infection (10%) </p>
<p><b>Common</b> (1% to 10%): Breathing difficulty, dyspnea, sinusitis, cough, pharyngitis, bronchitis, rhinitis, oropharyngeal pain<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Muscular weakness (up to 56%)</p>
<p><b>Common</b> (1% to 10%): Musculoskeletal pain, muscle atrophy, pain in extremity, back pain, wrist fracture</p>
<p><b>Uncommon</b> (0.1% to 1%): Gait disturbance, hypertonia</p>
<p><b>Postmarketing reports</b>: Amyotrophy<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection, influenza, neutralizing antibodies<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Excessive granulation tissue, erythema<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (12%)</p>
<p><b>Common</b> (1% to 10%): Fall, injury, contusion, ear infection, pyrexia</p>
<p><b>Uncommon</b> (0.1% to 1%): Sensation of heaviness</p>
<p><b>Frequency not reported</b>: Distant spread of toxin effects</p>
<p><b>Postmarketing reports</b>: Vertigo, burning sensation, hypoesthesia</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Dysport (abobotulinumtoxinA)." Tercica Inc, Brisbane, CA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Dysport vs Botox: What's the difference?</li>
<li>What is botulinum toxin used to treat?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Dysport (abobotulinumtoxinA)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>7 Reviews</li>
<li>Drug class: skeletal muscle relaxants</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Dysport &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Facial Wrinkles</li>
<li>Cervical Dystonia</li>
<li>Lower Limb Spasticity</li>
<li>Upper Limb Spasticity</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to abobotulinumtoxinA: injectable powder for injection, intramuscular powder for injection</i></p><h3>General</h3><p>The most commonly occurring side effects have included muscular weakness, dysphagia, dry mouth, injection site pain and discomfort, fatigue, headache, and nasopharyngitis.</p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dysphonia (up to 28%), headache (11%), facial paresis (up to 11%)</p><p><b>Common</b> (1% to 10%): Dizziness, convulsion, syncope, hypoesthesia, partial seizures<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, peripheral edema<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dysphagia (up to 39%), dry mouth (up to 39%)</p><p><b>Common</b> (1% to 10%): Nausea, diarrhea, constipation, vomiting, gastroenteritis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, blood present in urine<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Abnormal liver function tests<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Anaphylaxis, urticaria, soft tissue edema</p><p><b>Postmarketing reports</b>: Hypersensitivity reactions including anaphylaxis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Blood triglycerides increased<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Eye disorders (e.g., vision blurred, diplopia, visual acuity reduced, eye pain, eyelid disorder, accommodation disorder, dry eye, eye pruritus) (up to 17%)</p><p><b>Common</b> (1% to 10%): Eyelid edema, eyelid ptosis</p><p><b>Postmarketing reports</b>: Photophobia<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site discomfort (e.g., pain, bruising, hemorrhage, injection site erythema/hematoma) (up to 22%)</p><p><b>Common</b> (1% to 10%): Injection site pain<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Nasopharyngitis (10%), upper respiratory infection (10%) </p><p><b>Common</b> (1% to 10%): Breathing difficulty, dyspnea, sinusitis, cough, pharyngitis, bronchitis, rhinitis, oropharyngeal pain<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Muscular weakness (up to 56%)</p><p><b>Common</b> (1% to 10%): Musculoskeletal pain, muscle atrophy, pain in extremity, back pain, wrist fracture</p><p><b>Uncommon</b> (0.1% to 1%): Gait disturbance, hypertonia</p><p><b>Postmarketing reports</b>: Amyotrophy<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection, influenza, neutralizing antibodies<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Excessive granulation tissue, erythema<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (12%)</p><p><b>Common</b> (1% to 10%): Fall, injury, contusion, ear infection, pyrexia</p><p><b>Uncommon</b> (0.1% to 1%): Sensation of heaviness</p><p><b>Frequency not reported</b>: Distant spread of toxin effects</p><p><b>Postmarketing reports</b>: Vertigo, burning sensation, hypoesthesia</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Dysport (abobotulinumtoxinA)." Tercica Inc, Brisbane, CA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Dysport vs Botox: What's the difference?</li>
<li>What is botulinum toxin used to treat?</li>
</ul><h2>More about Dysport (abobotulinumtoxinA)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>7 Reviews</li>
<li>Drug class: skeletal muscle relaxants</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Dysport &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Facial Wrinkles</li>
<li>Cervical Dystonia</li>
<li>Lower Limb Spasticity</li>
<li>Upper Limb Spasticity</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>